Skip to main content
Carbidopa 25 mg/1 tablet by Novel Laboratories, Inc.
Carbidopa, 25 mg/1, tablet Available on prescription only. Listed by Novel Laboratories, Inc..
Prescription only Generic

Carbidopa

Listed by Novel Laboratories, Inc.

Strength
25 mg/1
Form
Tablet
Route
Oral

What it contains

  • Carbidopa 25 mg/1

FDA record

Dosage form Tablet
Route Oral
Approval route ANDA — approved generic
NDC code 40032-980
FDA application ANDA204763
RxNorm concept 260260
Package sizes listed 3
Marketed since October 2017

Other products containing Carbidopa

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Carbidopa

Strength
25 mg/1
Form
Tablet
Rx only Generic

Aurobindo Pharma Limited

Not stocked by us — reference only

Carbidopa

Strength
25 mg/1
Form
Tablet
Rx only Generic

Lupin Pharmaceuticals,Inc.

Not stocked by us — reference only

Carbidopa

Strength
25 mg/1
Form
Tablet
Rx only Generic

Edenbridge Pharmaceuticals LLC.

Not stocked by us — reference only

CARBIDOPA

Strength
25 mg/1
Form
Tablet
Rx only Generic

Zydus Lifesciences Limited

Not stocked by us — reference only

Carbidopa

Strength
25 mg/1
Form
Tablet
Rx only Generic

NorthStar Rx LLC

Not stocked by us — reference only

Carbidopa

Carbidopa Tablets

Strength
25 mg/1
Form
Tablet
Rx only

Oceanside Pharmaceuticals

Not stocked by us — reference only

CARBIDOPA

Strength
25 mg/1
Form
Tablet
Rx only Generic

Zydus Pharmaceuticals USA Inc.

Not stocked by us — reference only

Carbidopa and Levodopa

Strength
50 mg/1, 200 mg/1
Form
Tablet, Extended Release
Class
Aromatic Amino Acid
Rx only Generic

NCS HealthCare of KY, LLC dba Vangard Labs

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.